SARS-CoV-2 variants from mink evade inhibition by antibodies

It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals. Mutations were acquired in the spike protein, which is crucial for the entry of the virus into host cells and represents the central point of attack for antibodies. These SARS-CoV-2 variants from mink were transmitted back to humans, raising concerns that minks could be a continuing source of infection of humans with SARS-CoV-2 variants with altered biological properties. Researchers at the German Primate Center (DPZ) - Leibniz Institute for Primate Research in Göttingen, Germany, have now shown that an antibody used for COVID-19 therapy is unable to effectively inhibit SARS-CoV-2 harboring a spike mutation acquired in minks. In addition, the mutation reduced the inhibition of the virus by antibodies produced in SARS-CoV-2 infected humans. These results show that SARS-CoV-2 can acquire mutations in minks that may reduce control of the virus by the human immune system. The study and findings have been published in Cell Reports.

Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody

Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications

SARS-CoV-2 Variant Protein - Elabscience

Molecular variants of SARS-CoV-2: antigenic properties and current vaccine efficacy

Viruses, Free Full-Text

Full article: SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies

The Omicron variant is highly resistant against antibody-mediated neutralization – implications for control of the COVID-19 pandemic

The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice

Frontiers In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms

Frontiers The effects of amino acid substitution of spike protein and genomic recombination on the evolution of SARS-CoV-2

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity - ScienceDirect

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

COVID-19 mutation mapping identifies escape mutations against therapeutic antibodies

A review: Antibody-dependent enhancement in COVID-19: The not so friendly side of antibodies - Gabriela Athziri Sánchez-Zuno, Mónica Guadalupe Matuz-Flores, Guillermo González-Estevez, Ferdinando Nicoletti, Francisco Javier Turrubiates-Hernández, Katia

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals